ask="N/A"
ask_size="N/A"
average_daily_volume="504530"
bid="N/A"
bid_size="N/A"
book_value="6.19"
change="+0.86"
change_from_200_day_moving_average="4.36"
change_from_50_day_moving_average="2.55"
change_from_52_week_high="-5.56"
change_From_52_week_low="20.49"
change_in_percent="+2.65%"
close="33.36"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.06"
ebitda="-175.77M"
eps_estimate_current_year="-3.81"
eps_estimate_next_quarter="-1.03"
eps_estimate_next_year="-3.92"
ex_dividend_date="N/A"
float_shares="31803000"
high="33.62"
high_52_weeks="38.92"
last_trade_date="1/4/2017"
last_trade_price="33.36"
last_trade_size="26063"
last_trade_time="4:00pm"
low="32.44"
low_52_weeks="12.87"
market_capitalization="1.73B"
moving_average_200_day="29.00"
moving_average_50_day="30.81"
name="Theravance Biopharma
Inc. - Or"
notes="N/A"
one_year_target_price="34.71"
open="32.61"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="+15.02%"
percent_change_from_50_day_moving_average="+8.27%"
percent_change_from_52_week_high="-14.29%"
percent_change_from_52_week_low="+159.21%"
previous_close="32.50"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.25"
price_per_sales="36.03"
revenue="46.85M"
shares_outstanding="51942000"
short_ratio="13.10"
stock_exchange="NGM"
symbol="TBPH"
volume="306217"
weeks_range_52="12.87 - 38.92"
